Psoriatic Arthritis
News
Arthritis prevalence higher than previously thought, especially in adults under 65
Two additional survey questions greatly improved sensitivity for arthritis.
News
FDA approves IL-17A antagonist for treating psoriatic arthritis
Ixekizumab was compared with placebo in two phase 3 studies of patients with psoriatic arthritis.
Conference Coverage
Expert discusses risks of biosimilars in rheumatology
In the opinion of J. Eugene Huffstutter, MD, the expected risks of biosimilar products have clinicians concerned, especially when it comes to...
Conference Coverage
Topical tapinarof heads for phase 3 in atopic dermatitis and psoriasis
GENEVA – The aryl hydrocarbon receptor agonist is first-in-class.
Conference Coverage
VIDEO: New PsA guideline expected in 2018
TNF inhibitor biologics are recommended as first-line therapy.
Latest News
Ustekinumab may reduce risk of nonmelanoma skin cancer
GENEVA – Risk was also lower among psoriasis patients treated with a TNF-inhibitor, but the difference was not significant.
Conference Coverage
Moderate psoriasis: the new frontier for systemic therapies
UNVEIL trial shows apremilast hits the mark in this population.
News
PsA disease activity instruments differ on residual disease
Measurement of disease activity with certain tools may miss residual disease, such as psoriasis, despite meeting criteria for low disease activity...
Latest News
Guselkumab tops adalimumab for psychiatric comorbidities in psoriasis
Treatment with guselkumab was associated with significantly greater improvements in anxiety and depression.
Latest News
Psoriasis patients face higher risk of alcohol-related death – but lower suicide risk
GENEVA – But a large U.K. study using the same database showed they have a below-average suicide rate.